Microalbuminuria is associated with insulin resistance in nondiabetic subjects: The insulin resistance atherosclerosis study

Diabetes

Volumn 47, Issue 5, 1998, Pages 793-800

  Mykkänen, Leena ^a   Zaccaro, Daniel J ^b   Wagenknecht, Lynne E ^b   Robbins, David C ^c   Gabriel, Maggy ^a,d   Haffner, Steven M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c Medlantic Research Institute   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RESPONSE; CORONARY RISK; DIABETES MELLITUS; FEMALE; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0346939291     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.5.793     Document Type: Article

References (61)

1. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432, 1982
2. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
3. Mogensen CE: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 310:356-360, 1984
4. Jarrett JR, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1:17-19, 1984
5. Schmitz A, Vaeth M: Microalbuminuria: a major risk factor in non-insulin-dependent diabetes: a 10-year follow-up study of 503 patients. Diabet Med 5:126-134, 1988
6. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G: Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 41:735-741, 1992
7. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 2:530-533, 1988
8. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. BMJ 300:297-300, 1990
9. Kuusisto J, Mykkänen L, Pyorala K, Laakso M: Hyperinsulinemic microalbuminuria: a new risk indicator for coronary heart disease. Circulation 91:831-837, 1995
10. Groop L, Ekstrand A, Forsblom C, Widén E, Groop P-H, Teppo A-M, Eriksson J: Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:642-647, 1993
11. Niskanen L, Laakso M: Insulin resistance is related to albuminuria in patients with type II (non-insulin-dependent) diabetes mellitus. Metabolism 42:1541-1545, 1993
12. Nosadini R, Solini A, Velussi M, Muollo B, Frigato F, Sambataro M, Cipollina MR, De Riva F, Brocco E, Crepaldi G: Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes 43:491-499, 1994
13. Nielsen S, Orskov H, Schmitz O, Mogensen CE: Similar insulin sensitivity in NIDDM patients with normo- and microalbuminuria. Diabetes Care 18:834-842, 1995
14. Forsblom CM, Eriksson JG, Ekstrand AV, Teppo A-M, Taskinen M-R, Groop LC: Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 38:363-369, 1995
15. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
16. Laakso M, Sarlund H, Mykkänen L: Essential hypertension and insulin resistance in non-insulin-dependent diabetes. Eur J Clin Invest 19:518-526, 1989
17. Ferrannini E, Natali A, Capaldo B, Lehtovirta M, Jacob S, Yki-Järvinen H, for the European Group for the Study of Insulin Resistance (EGIR): Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. Hypertension 30:1144-1149, 1997
18. Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock J, Raskin P: Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37:982-987, 1988
19. Laakso M, Sarlund H, Mykkänen L: Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 10:223-231, 1990
20. Mattock MB, Keen H, Viberti GC, El-Gohari MR, Murrells TJ, Scott GS, Wing JR, Jackson PG: Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 31:82-87, 1988
21. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Voutilainen E, Penttila I, Pyorala K: Microalbuminuria predicts the development of serum lipoprotein abnormalities favoring atherogenesis in newly diagnosed type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33:237-243, 1990
22. Haffner SM, Gonzales C, Valdez RA, Mykkänen L, Hazuda HP, Mitchell BD, Monterrosa A, Stern MP: Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 36:1002-1006, 1993
23. Mykkänen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes 43:552-557, 1994
24. Yki-Järvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992
25. Groop L, Makipernaa A, Stenman S, DeFronzo RA, Teppo AM: Urinary excretion of kappa light chains in patients with diabetes mellitus. Kidney Int 37:1120-1125, 1990
26. Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin G, Groop L: Early metabolic defects in persons at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med 321:337-343, 1989
27. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. Ann Intern Med 113:903-915, 1990
28. Gulli G, Ferrannini E, Stern MP, Haffner SM, DeFronzo RA: The metabolic profile of NIDDM is fully established in normal glucose tolerant offspring of two diabetic parents. Diabetes 41:1575-1586, 1992
29. Wagenknecht LE, Mayer EJ, Rewers M, Haffner SM, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design and recruitment results. Ann Epidemiol 5:464-471, 1995
30. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ: Sex difference in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol 120:834-851, 1984
31. Hamman RF, Marshall JA, Baxter J, Kahn LB, Mayer EJ, Orleans M, Murphy JR, Lezotte DC: Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study. Am J Epidemiol 129:295-311, 1989
32. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
33. Herbert V, Lau K, Gottlieb C, Bleicher S: Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965
34. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocrine Rev 6:45-86, 1985
35. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
36. Welch S, Gebhart SSP, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 71:1508-1518, 1990
37. Steil GM, Volund A, Kahn SE, Bergman RN: Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model: suitability for use in population studies. Diabetes 42:250-256, 1993
38. Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YDI, Sands RE, Pei D, Savage PJ, Bergman RN: A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
39. Haffner SM, D'Agostino R Jr, Saad MF, Rewers M, Mykkänen L, Selby J, Howard G, Savage PJ, Hamman RF, Wagenknecht LE, Bergman RN: Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared to non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Diabetes 45:742-748, 1996
40. Kroll MH, Chesler R, Hagengruber C, Blank DW, Kestner J, Rawe M: Automated determination of urinary creatinine without sample dilution: theory and practice. Clin Chem 32:446-452, 1986
41. Galling W, Knight C, Mullee MA, Hill RD: Microalbuminuria in diabetes: a population study of the prevalence and an assessment of three screening tests. Diabet Med 5:343-347, 1988
42. Hutchison AS, O'Reilly DSJ, McCuish AC: Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem 34:2019-2021, 1988
43. Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Charles MA, Bennett PH: Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Arch Intern Med 151:1761-1765, 1991
44. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989, p. 148-149
45. Parving HH, Mogensen CE, Jensen HE, Evrin PE: Increased urinary albumin-excretion rate in benign essential hypertension. Lancet i:1190-1192, 1974
46. Haffner SM, Stern MP, Gruber KK, Hazuda HP, Mitchell BD, Patterson JK: Microalbuminuria: potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 10:727-731, 1990
47. Bigazzi R, Bianchi S, Canpese VM, Baldari G: Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 61:94-97, 1992
48. Saad MF, Lillioja S, Nyomba BL, Castillo C, Ferraro R, De Gregorio M, Ravussin E, Knowler WC, Bennett PH, Howard BV, Bogardus CI: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324:733-739, 1991
49. SAS Institute: SAS/STAT User's Guide, Version 6, 4th ed., Vol. 2, Cary, NC, SAS Institute, 1989
50. SAS Institute: SAS Technical Report P-243, SAS/STAT Software: the GENMOD Procedure, Release 6.09. Cary, NC, SAS Institute, 1993
51. Ferrannini E: Metabolic abnormalities of hypertension: a lesson in complexity. Hypertension 18:636-639, 1991
52. Haffner SM: Insulin and blood pressure: fact or fantasy? J Clin Endocrinol Metab 76:541-543, 1993
53. Anderson EA, Mark AL: The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 21:136-141, 1993
54. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39:167-174, 1990
55. Falkner B, Hulman S, Kushner H: Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 22:18-25, 1993
56. Scaglione R, Ganguzza A, Corrao S, Parrinello G, Merlino G, Dichiara MA, Arnone S, D'Aubert MD, Licata G: Central obesity and hypertension: pathophysiologic role of renal haemodynamic and function. Int J Obes 19:403-409, 1995
57. Peiris AN, Hennes Ml, Evans DJ, Wilson CR, Lee MB, Kissebah AH: Relationship of anthropometric measurements of body fat distribution to metabolic profile in premenopausal women. Acta Med Scand Suppl 723:179-188, 1988
58. Seidell JC, Bjorntorp P, Sjostrom L, Sannerstedt R, Krotkiewski M, Kvist H: Regional distribution of muscle and fat mass in men: new insight into the risk of abdominal obesity using computed tomography. Int J Obes 13:289-303, 1989
59. Tucker BJ, Anderson CM, Thies RS, Collins RC, Blantz RC: Glomerular hemodynamic alterations during acute hyperinsulinemia in normal and diabetic rats. Kidney Int 42:1160-1168, 1992
60. Cohen AJ, McCarthy DM, Stoff JS: Direct hemodynamic effect of insulin in the isolated perfused kidney. Am J Physiol 257:F580-F585, 1989
61. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23:647-655, 1983